--- title: "Request for Information - Oligonucleotides Onshoring" ocid: "ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61.json" source: "Contracts Finder" current_stage: "Planning" buyer: "UK HEALTH SECURITY AGENCY" published: "2026-06-12" --- # Request for Information - Oligonucleotides Onshoring Buyer: UK HEALTH SECURITY AGENCY Current stage: Planning OCID: ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61.json) ## Summary The UK Health Security Agency (UKHSA) is in the planning stage of a tender titled "Request for Information - Oligonucleotides Onshoring," classified under the industry category of laboratory reagents. The procurement process, initiated on 12th June 2026, targets enhancing understanding of the oligonucleotide market with a focus on onshore manufacturing capabilities within the UK. This Request for Information (RFI) is not a sourcing exercise but aims to gather insights to inform future procurement strategies. The engagement end date is set for 10th July 2026, with responses being an integral part of shaping UKHSA’s subsequent approach to improving access to oligonucleotide products. The buying organisation is based in London, with the postal code E14 4PU. This procurement process presents an opportunity for businesses involved in the manufacture and supply of oligonucleotides to contribute to UKHSA's understanding of the market and its manufacturing landscape. Companies with robust capabilities in the production of synthetic oligonucleotides, particularly those focusing on diagnostics and biosecurity applications, can leverage this RFI to position themselves for future contracts. The tender encourages domestic as well as international manufacturers, particularly those looking to expand or establish operations in the UK, to engage with UKHSA. While not suited for Small and Medium Enterprises (SMEs) or Voluntary, Community and Social Enterprises (VCSEs), larger businesses in the biotech and pharmaceutical sectors may find this an ideal venture for growth and collaboration with a significant public health entity. ## Notice 1. The purpose of this notice is to enhance the Authority's understanding of the marketplace and its options for sourcing for a potential future requirement. 2. The issuance of this request for information (RFI) does not constitute a sourcing exercise nor will the Authority pay any costs incurred in the preparation of a response to this RFI. 3. The UK Health Security Agency's (UKHSA) key objectives for this RFI are: a. understand the ability of the marketplace to fulfil its requirements; b. refine the scope of the requirements to best align to the marketplace; and c. inform the Authority's chosen route to market to best enable competition Description of Scope of Requirements: UKHSA sees access to oligonucleotide manufacturers as key to increasing the UK's biosecurity, preparedness and resilience for infectious diseases. Oligonucleotides are a ubiquitous reagent used widely at many stages for research, development and use of diagnostics and countermeasures for infectious disease. Synthetic oligonucleotides are used widely as essential components of molecular diagnostic assays, sequencing methods and for development of serological assays, as well as critical reagents in the research, development and manufacture of new vaccines and therapeutics. The market for oligonucleotide supply in the UK, when you include use outside of infectious disease-related applications, is significant. UKHSA would like to understand the breadth and depth of oligonucleotide manufacturing capability in the UK and globally. This includes what oligonucleotides are already being manufactured, and to what design, what dependencies or bottlenecks exist, how these are being applied to make a product, and the existing and potential scale of manufacturing capacity. Although UKHSA is interested in understanding international manufacturing capability, UKHSA is specifically interested in improving onshore manufacturing capability for oligonucleotides and would encourage respondents to reflect any future intentions in the UK. This information will be used to inform UKHSA's future approach to improve access to oligonucleotide products, and engagement with oligonucleotide manufacturers about UKHSA's requirements. Should you wish to respond to this Request for Information, please complete the response questionnaire which is found at the following link: https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001dZ2lOIAS&searchStr=request+for+inform ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/5a7709b3-44af-479f-b9f3-872c3c87bd24 | | Notice type | Market Engagement Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 12 Jun 2026 | | Submission deadline | Not specified | | Future notice date | 10 Jul 2026 | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planning | | Lots status | Not specified | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | UK HEALTH SECURITY AGENCY | | Locality | LONDON | | Post town | East London | | Postcode | E14 4PU | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI42 Tower Hamlets | | Local authority | Tower Hamlets | | Electoral ward | Canary Wharf | | Westminster constituency | Poplar and Limehouse | | Delivery location | Not specified | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33696500 - Laboratory reagents ## Release History - 12 Jun 2026 at 18:18 - Planning - Market Engagement Notice - https://www.contractsfinder.service.gov.uk/Notice/5a7709b3-44af-479f-b9f3-872c3c87bd24 ## Documents - https://www.contractsfinder.service.gov.uk/Notice/5a7709b3-44af-479f-b9f3-872c3c87bd24 12th June 2026 - Early engagement notice on Contracts Finder - https://www.contractsfinder.service.gov.uk/Notice/Attachment/da87915a-39fb-429a-8c3b-bf494e817519 20260612_RFI_Oligonucleotides_C450524 ## Notice URLs - https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a07Pz00001dZ2lOIAS&searchStr=request+for+inform ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-52499bb7-2e61-4453-a285-d49e959c0e61.json.